BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2595803)

  • 1. Plasma HDL cholesterol, triglyceride and total cholesterol levels in non insulin treated Nigerian diabetics.
    Erasmus RT; Bojuwoye BJ; Olukoga O; Adewoye H
    Trop Geogr Med; 1989 Jul; 41(3):238-41. PubMed ID: 2595803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triglyceride profile in dyslipidaemia of type 2 diabetes mellitus.
    Khan SR; Ayub N; Nawab S; Shamsi TS
    J Coll Physicians Surg Pak; 2008 May; 18(5):270-3. PubMed ID: 18541079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased LDL cholesterol in non-insulin-dependent diabetics with maculopathy.
    Mohan R; Mohan V; Susheela L; Ramachandran A; Viswanathan M
    Acta Diabetol Lat; 1984; 21(1):85-9. PubMed ID: 6730849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of obesity and hypertriglyceridaemia on the low HDL2-cholesterol level and on its relationship with prevalence of atherosclerosis in type 2 diabetes.
    Verges B; Brun JM; Vaillant G; Quantin C; Brunet-Lecomte P; Farnier M; Gambert P
    Diabete Metab; 1992; 18(4):289-97. PubMed ID: 1459317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Factors affecting serum lipid levels in patients with type 2 diabetes mellitus].
    Tkác I; Tkácová R; Molcányiová A; Mudríková T; Takác M
    Vnitr Lek; 1994 Jan; 40(1):17-20. PubMed ID: 8140744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term (18-month) efficacy of atorvastatin therapy in type 2 diabetics at cardiovascular risk.
    Velussi M
    Nutr Metab Cardiovasc Dis; 2002 Feb; 12(1):29-35. PubMed ID: 12125227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary risk and dyslipidemia in type 2 diabetic patients.
    Udawat H; Goyal RK; Maheshwari S
    J Assoc Physicians India; 2001 Oct; 49():970-3. PubMed ID: 11848328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diacylglycerol oil ingestion in type 2 diabetic patients with hypertriglyceridemia.
    Yamamoto K; Takeshita M; Tokimitsu I; Watanabe H; Mizuno T; Asakawa H; Tokunaga K; Tatsumi T; Okazaki M; Yagi N
    Nutrition; 2006 Jan; 22(1):23-9. PubMed ID: 16289977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low HDL-cholesterol is common in European Type 2 diabetic patients receiving treatment for dyslipidaemia: data from a pan-European survey.
    Bruckert E; Baccara-Dinet M; Eschwege E
    Diabet Med; 2007 Apr; 24(4):388-91. PubMed ID: 17335463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma lipids and lipoproteins in type II diabetic Nigerians with retinopathy.
    Erasmus RT; Alanamu RA; Bojuwoye B
    Trop Geogr Med; 1991; 43(1-2):55-8. PubMed ID: 1750130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma lipid profiles in relation to diabetic control in Nigerians.
    Akanji AO; Agbedana EO; Ugbode C
    Afr J Med Med Sci; 1989 Sep; 18(3):229-34. PubMed ID: 2551165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The lipid triad in type 2 diabetes - prevalence and relevance of hypertriglyceridaemia/low high-density lipoprotein syndrome in type 2 diabetes.
    Temelkova-Kurktschiev T; Hanefeld M
    Exp Clin Endocrinol Diabetes; 2004 Feb; 112(2):75-9. PubMed ID: 15031770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein alterations in hemodialysis: differences between diabetic and nondiabetic patients.
    González AI; Schreier L; Elbert A; Berg G; Beresan H; López G; Wikinski R
    Metabolism; 2003 Jan; 52(1):116-21. PubMed ID: 12524671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of lipid profiles and lipoprotein a levels in patients with type 2 diabetes mellitus during oral hypoglycemic or insulin therapy.
    Habib SS; Aslam M; Naveed AK; Razi MS
    Saudi Med J; 2006 Feb; 27(2):174-80. PubMed ID: 16501671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [HDL cholesterol in diabetes mellitus type II].
    Valesano G; Magnacca M
    Minerva Med; 1989 Mar; 80(3):261-4. PubMed ID: 2717046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simvastatin treatment on postprandial hypertriglyceridemia in type 2 diabetes mellitus patients with combined hyperlipidemia.
    Sheu WH; Jeng CY; Lee WJ; Lin SY; Pei D; Chen YT
    Metabolism; 2001 Mar; 50(3):355-9. PubMed ID: 11230791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Social class and risk factors for vascular disease in diabetes.
    Robinson N; Edouard L; Diehl A; Fuller JH
    Diabete Metab; 1984 Oct; 10(4):245-9. PubMed ID: 6391975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Levels of HDL cholesterol and the HDL2 and HDL3 subfractions in newly detected type 2 diabetes].
    Brunová J; Válek J; Grafnetter D; Karasová L
    Vnitr Lek; 1989 Mar; 35(3):292-8. PubMed ID: 2734999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lipoprotein (a) and ischemic heart diseases in patients with type 2 diabetes].
    Ben Hamda K; Masmoudi AS; Mandhouj O; Hammami S; Attia N; Smaoui M; Zidi MA; Nabli N; Chaaba R; Mahjoub S; Ben Farhat M; Hammami M
    Arch Inst Pasteur Tunis; 2002; 79(1-4):27-33. PubMed ID: 15072242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma lipid profiles and vascular disease in type 2 (non-insulin dependent) Nigerian diabetic patients.
    Agbedana EO; Akanji AO
    Trop Geogr Med; 1988 Apr; 40(2):88-92. PubMed ID: 3407012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.